Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel

The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high...

Full description

Bibliographic Details
Main Authors: Shmuel Stienlauf, Vered Yahalom, Eli Schwartz, Eilat Shinar, Gad Segal, Yechezkel Sidi
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2009-07-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/15/7/08-0796_article
_version_ 1818413503276384256
author Shmuel Stienlauf
Vered Yahalom
Eli Schwartz
Eilat Shinar
Gad Segal
Yechezkel Sidi
author_facet Shmuel Stienlauf
Vered Yahalom
Eli Schwartz
Eilat Shinar
Gad Segal
Yechezkel Sidi
author_sort Shmuel Stienlauf
collection DOAJ
description The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.
first_indexed 2024-12-14T11:04:14Z
format Article
id doaj.art-8969adbaf6114ab0b04d3f00e522d5b0
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-14T11:04:14Z
publishDate 2009-07-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-8969adbaf6114ab0b04d3f00e522d5b02022-12-21T23:04:37ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592009-07-011571116111810.3201/eid1507.080796Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, IsraelShmuel StienlaufVered YahalomEli SchwartzEilat ShinarGad SegalYechezkel SidiThe prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.https://wwwnc.cdc.gov/eid/article/15/7/08-0796_articleKeywords: HTLV-1 infectionshuman T-cell lymphotropic virus type 1virusesepidemiologyIsraelemigration and immigration
spellingShingle Shmuel Stienlauf
Vered Yahalom
Eli Schwartz
Eilat Shinar
Gad Segal
Yechezkel Sidi
Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
Emerging Infectious Diseases
Keywords: HTLV-1 infections
human T-cell lymphotropic virus type 1
viruses
epidemiology
Israel
emigration and immigration
title Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_full Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_fullStr Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_full_unstemmed Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_short Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
title_sort epidemiology of human t cell lymphotropic virus type 1 infection in blood donors israel
topic Keywords: HTLV-1 infections
human T-cell lymphotropic virus type 1
viruses
epidemiology
Israel
emigration and immigration
url https://wwwnc.cdc.gov/eid/article/15/7/08-0796_article
work_keys_str_mv AT shmuelstienlauf epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT veredyahalom epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT elischwartz epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT eilatshinar epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT gadsegal epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael
AT yechezkelsidi epidemiologyofhumantcelllymphotropicvirustype1infectioninblooddonorsisrael